We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Undifferentiated non-Hodgkin's lymphomas (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction.
- Authors
Miliauskas, John A.; Berard, Costan W.; Young, Robert C.; Garvin, A. Julian; Edwards, Brenda K.; Devita, Vincent T.; Miliauskas, J R; Berard, C W; Young, R C; Garvin, A J; Edwards, B K; DeVita, V T Jr
- Abstract
A retrospective study of 66 cases of undifferentiated non-Hodgkin's lymphomas at the National Cancer Institute over a 22-year period suggests that the histologic distinction between Burkitt's and non-Burkitt's types is clinicopathologically meaningful. Thirty-nine patients with Burkitt's lymphoma had a median age at presentation of ten years. The primary site of disease in these patients was more commonly extranodal; at the time of diagnosis 26 (66%) of these cases revealed intra-abdominal involvement; 25 (64%) of the cases were Stage IV. The 27 patients with non-Burkitt's lymphomas had a median age at presentation of 34 years; the primary site of disease was more commonly nodal (peripheral adenopathy was often present at the time of diagnosis); only nine (33%) of the cases were Stage IV. Median survival was essentially equivalent in the two groups, 9.5 months for Burkitt's lymphoma and 10.0 months for the non-Burkitt's lymphoma. Overall, survival was not significantly different among the two patient populations; however, patients with Burkitt's lymphoma had a longer survival than those with non-Burkitt's lymphoma. Estimates of five-year survival (with 95% confidence) are 42% for Burkitt's lymphoma and 11% for non-Burkitt's lymphoma, respectively, which are significantly different (P = 0.01).
- Publication
Cancer (0008543X), 1982, Vol 50, Issue 10, p2115
- ISSN
0008-543X
- Publication type
journal article
- DOI
10.1002/1097-0142(19821115)50:10<2115::AID-CNCR2820501024>3.0.CO;2-9